Medigen Biotechnology (Taiwan) Market Value
| 3176 Stock | TWD 31.00 0.30 0.98% |
| Symbol | Medigen |
Medigen Biotechnology 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Medigen Biotechnology's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Medigen Biotechnology.
| 05/06/2025 |
| 08/04/2025 |
If you would invest 0.00 in Medigen Biotechnology on May 6, 2025 and sell it all today you would earn a total of 0.00 from holding Medigen Biotechnology or generate 0.0% return on investment in Medigen Biotechnology over 90 days. Medigen Biotechnology is related to or competes with EMemory Technology, Sinbon Electronics, Accton Technology, China Bills, Lotes, Silergy Corp, and Chroma ATE. More
Medigen Biotechnology Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Medigen Biotechnology's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Medigen Biotechnology upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.07) | |||
| Maximum Drawdown | 9.96 | |||
| Value At Risk | (3.18) | |||
| Potential Upside | 2.79 |
Medigen Biotechnology Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Medigen Biotechnology's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Medigen Biotechnology's standard deviation. In reality, there are many statistical measures that can use Medigen Biotechnology historical prices to predict the future Medigen Biotechnology's volatility.| Risk Adjusted Performance | 1.0E-4 | |||
| Jensen Alpha | (0.04) | |||
| Total Risk Alpha | (0.24) | |||
| Treynor Ratio | (0.13) |
Medigen Biotechnology Backtested Returns
At this stage we consider Medigen Stock to be very steady. Medigen Biotechnology has Sharpe Ratio of 0.0496, which conveys that the firm had a 0.0496 % return per unit of risk over the last 3 months. We have found twenty-three technical indicators for Medigen Biotechnology, which you can use to evaluate the volatility of the firm. Please verify Medigen Biotechnology's Mean Deviation of 1.19, standard deviation of 1.66, and Risk Adjusted Performance of 1.0E-4 to check out if the risk estimate we provide is consistent with the expected return of 0.076%. Medigen Biotechnology has a performance score of 3 on a scale of 0 to 100. The company secures a Beta (Market Risk) of 0.15, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Medigen Biotechnology's returns are expected to increase less than the market. However, during the bear market, the loss of holding Medigen Biotechnology is expected to be smaller as well. Medigen Biotechnology right now secures a risk of 1.53%. Please verify Medigen Biotechnology mean deviation, standard deviation, total risk alpha, as well as the relationship between the coefficient of variation and jensen alpha , to decide if Medigen Biotechnology will be following its current price movements.
Auto-correlation | 0.03 |
Virtually no predictability
Medigen Biotechnology has virtually no predictability. Overlapping area represents the amount of predictability between Medigen Biotechnology time series from 6th of May 2025 to 20th of June 2025 and 20th of June 2025 to 4th of August 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Medigen Biotechnology price movement. The serial correlation of 0.03 indicates that only 3.0% of current Medigen Biotechnology price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.03 | |
| Spearman Rank Test | -0.03 | |
| Residual Average | 0.0 | |
| Price Variance | 0.14 |
Medigen Biotechnology lagged returns against current returns
Autocorrelation, which is Medigen Biotechnology stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Medigen Biotechnology's stock expected returns. We can calculate the autocorrelation of Medigen Biotechnology returns to help us make a trade decision. For example, suppose you find that Medigen Biotechnology has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Medigen Biotechnology regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Medigen Biotechnology stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Medigen Biotechnology stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Medigen Biotechnology stock over time.
Current vs Lagged Prices |
| Timeline |
Medigen Biotechnology Lagged Returns
When evaluating Medigen Biotechnology's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Medigen Biotechnology stock have on its future price. Medigen Biotechnology autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Medigen Biotechnology autocorrelation shows the relationship between Medigen Biotechnology stock current value and its past values and can show if there is a momentum factor associated with investing in Medigen Biotechnology.
Regressed Prices |
| Timeline |
Pair Trading with Medigen Biotechnology
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Medigen Biotechnology position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medigen Biotechnology will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Medigen Biotechnology could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Medigen Biotechnology when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Medigen Biotechnology - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Medigen Biotechnology to buy it.
The correlation of Medigen Biotechnology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Medigen Biotechnology moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Medigen Biotechnology moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Medigen Biotechnology can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Medigen Stock Analysis
When running Medigen Biotechnology's price analysis, check to measure Medigen Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medigen Biotechnology is operating at the current time. Most of Medigen Biotechnology's value examination focuses on studying past and present price action to predict the probability of Medigen Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medigen Biotechnology's price. Additionally, you may evaluate how the addition of Medigen Biotechnology to your portfolios can decrease your overall portfolio volatility.